Immunic Inc. is facing potential delisting from the Nasdaq Stock Market due to non-compliance with the minimum bid price requirement. The company’s stock price closed below $1.00 for 30 consecutive business days, triggering a notice from Nasdaq. After failing to regain compliance within the initial 180-day grace period, Immunic transferred its listing from the Nasdaq Global Select Market to the Nasdaq Capital Market, receiving an additional 180 days, until June 22, 2026, to meet the $1.00 minimum bid price for at least 10 consecutive business days. If Immunic does not regain compliance, Nasdaq may delist the company’s shares, though Immunic would have the opportunity to appeal. The company has indicated it may implement a reverse stock split if necessary to meet the requirement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Immunic Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193805-26-000011), on January 06, 2026, and is solely responsible for the information contained therein.